E

Endocrine and Psychiatry Center | Houston, TX

Research site

(Unclaimed)

Location

9539 Huffmeister Road, Houston, Texas, United States of America

Site insights

Top conditions

Top treatments

Zenagamtide

Lorcaserin HCl

Avexitide

BELVIQ

Insulin icodec

Sugar

LY3209590

Testosterone

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials

A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity (AMBIENCE)

This clinical study is being conducted to evaluate the safety and effectiveness of zenagamtide in people with atherosclerotic cardiovascular disease...

Begins enrollment this month

Obesity

Cardiovascular Risk

Drug: Zenagamtide

Drug: Placebo

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

This study is being conducted to find out how well zenagamtide works and how safe it is compared to insulin glargine in participants with type 2 diab...

Enrolling

Cardiovascular Risk

Type 2 Diabetes

Drug: Zenagamtide

Drug: Insulin glargine U-100

Avexitide for Treatment of Post-Bariatric Hypoglycemia (LUCIDITY)

AVX-001 (LUCIDITY) is a Phase 3 study to evaluate avexitide compared to placebo in participants with post bariatric hypoglycemia (PBH) related to Rou...

Active, not recruiting

Post Bariatric Hypoglycemia

Drug: Avexitide

Other: Placebo